DHEA.

DHEA is converted in peripheral tissue into estrogen, which helps restrain the resorption side of normal bone remodeling, while vitamin D drives the calcium absorption and mineralization that build bone. The two support complementary steps of everyday bone maintenance as hormone output shifts with age.

Pantothenic acid becomes coenzyme A, which carries the acetyl units used to build cholesterol and then pregnenolone, the step directly upstream of DHEA. It is the classic adrenal cofactor in this pathway.

Zinc status shapes several steroidogenic and steroid-metabolising enzymes, including aromatase activity that decides where DHEA-derived androgens end up. It changes the downstream split rather than the DHEA level itself.

Boron shifts the fraction of steroid hormones bound to carrier proteins, raising free hormone at the same total. That affects what DHEA-derived androgens are available to tissue.

The adrenal cortex holds one of the highest ascorbate concentrations in the body and uses it in hydroxylation and redox steps of steroid production. Adequate ascorbate keeps that machinery running.

Magnesium lowers the binding affinity of sex hormone binding globulin, which raises the free share of DHEA-derived androgens. The total does not change but the usable fraction does.

Calcium D-glucarate slows intestinal beta-glucuronidase, so glucuronidated steroid metabolites leave the body instead of being cleaved and reabsorbed. It acts on the clearance side of the DHEA cascade.

Cruciferous constituents shift hydroxylation of DHEA-derived oestrogens toward the 2-hydroxy route and induce phase II conjugation. That changes the metabolite mix rather than the parent hormone.

Ashwagandha acts on HPA axis signalling and cortisol output, which shares the adrenal cortex with DHEA production. Blends use it alongside DHEA to work on the regulatory side rather than the substrate side.

Glycyrrhizin slows 11-beta-hydroxysteroid dehydrogenase type 2, changing how cortisol is handled in the same tissues that process DHEA. The pairing is meaningful but it also means two adrenal-axis levers are being pulled at once.

Tongkat ali releases androgens from their binding proteins while DHEA adds to the precursor pool. Supply and availability are different levers on the same axis.

Red clover isoflavones bind oestrogen receptors directly, and part of a DHEA dose converts onward to oestradiol. Taken together the two push the same receptor signalling from two directions.

Steroidogenesis begins with cholesterol side-chain cleavage inside the mitochondrion, a step that depends on electron transport running normally. Coenzyme Q10 carries electrons within that chain. The two are commonly combined in reproductive-support formulations on that mechanistic basis, and the combination itself has not been isolated in a trial.

Melatonin concentrates in follicular fluid and acts there as a direct radical scavenger. DHEA is used as an androgen precursor in the same setting. They are combined for different reasons rather than a shared pathway, and no trial has separated their contributions.

DHEA is converted peripherally to androstenedione and onward to both testosterone and estradiol, and a meta-analysis in postmenopausal women reported that supplementation raises both hormones. DIM shifts hepatic estrogen hydroxylation toward the 2-hydroxy route. Combining them changes the metabolite distribution downstream of DHEA, not the amount converted.

Testosterone derived from DHEA is converted to dihydrotestosterone by 5-alpha-reductase, and saw palmetto lipid extract inhibits that enzyme in laboratory work. Taken together, the second ingredient acts on where the first one's downstream product goes. This is a directional interaction rather than an additive one, and it has not been measured in a combination trial.

Selenium is required for glutathione peroxidase, the enzyme system that limits peroxide accumulation in steroid-producing tissue. Steroidogenesis generates reactive oxygen species as a by-product of cytochrome P450 cycling. The pairing is mechanistic, with no combination data.

Alpha-tocopherol terminates lipid peroxidation chains in membranes, including the cholesterol-rich membranes where steroid synthesis happens. DHEA supplementation raises flux through those pathways. The rationale is mechanistic and untested as a pair.

Carnitine moves long-chain fatty acids into mitochondria for oxidation, which is the energy supply that steroidogenic and germ cells depend on. DHEA works on hormone precursor supply instead. They are combined in the same product category for complementary rather than overlapping reasons.

Pregnenolone sits immediately upstream of DHEA, converted by CYP17A1 through 17-hydroxypregnenolone. Supplying both loads the same pathway at two points, and the downstream outcome still depends on tissue enzyme expression rather than on how much precursor arrives. Stacking precursors does not give proportional control over the end products.